December 2023 Erie Insurance Property & Casualty Company
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
ASSETS
|
Current Year |
Prior Year |
||||||||
|
1 |
2 |
3 |
4 |
||||||
|
Net Admitted Assets |
Net Admitted |
||||||||
|
Assets |
Nonadmitted Assets |
(Cols. 1 - 2) |
Assets |
||||||
|
1. |
Bonds (Schedule D) |
12,951,575 |
................................... |
12,951,575 |
12,385,853 |
||||
|
2. |
Stocks (Schedule D): |
||||||||
|
2.1 Preferred stocks |
................................... |
................................... |
................................... |
................................... |
|||||
|
2.2 Common stocks |
................................... |
................................... |
................................... |
................................... |
|||||
|
3. |
Mortgage loans on real estate (Schedule B): |
||||||||
|
3.1 First liens |
................................... |
................................... |
................................... |
................................... |
|||||
|
3.2 Other than first liens |
................................... |
................................... |
................................... |
................................... |
|||||
|
4. |
Real estate (Schedule A): |
||||||||
|
4.1 Properties occupied by the company (less $ |
|||||||||
|
encumbrances) |
................................... |
................................... |
................................... |
................................... |
|||||
|
4.2 Properties held for |
the production of income (less |
||||||||
|
$ |
encumbrances) |
................................... |
................................... |
................................... |
................................... |
||||
|
4.3 Properties held for sale (less $ |
|||||||||
|
.......................................................................................encumbrances) |
................................... |
................................... |
................................... |
................................... |
|||||
|
5. |
Cash ($ |
(3,810) , Schedule E - Part 1), cash equivalents |
|||||||
|
($ |
665,573 |
, Schedule E - Part 2) and short-term |
|||||||
|
investments ($ |
................................... |
, Schedule DA) |
661,763 |
................................... |
661,763 |
1,302,849 |
|||
|
6. |
Contract loans (including $ |
................................... premium notes) |
................................... |
................................... |
................................... |
................................... |
|||
|
7. |
Derivatives (Schedule DB) |
................................... |
................................... |
................................... |
................................... |
||||
|
8. |
Other invested assets (Schedule BA) |
................................... |
................................... |
................................... |
................................... |
||||
|
9. |
Receivable for securities |
382,950 |
................................... |
382,950 |
5,020 |
||||
|
10. |
Securities lending reinvested collateral assets (Schedule DL) |
................................... |
................................... |
................................... |
................................... |
||||
|
11. |
Aggregate write-ins for invested assets |
................................... |
................................... |
................................... |
................................... |
||||
|
12. |
Subtotals, cash and invested assets (Lines 1 to 11) |
13,996,288 |
................................... |
13,996,288 |
13,693,722 |
||||
|
13. |
Title plants less $ |
charged off (for Title insurers |
|||||||
|
only) |
................................... |
................................... |
................................... |
................................... |
|||||
|
14. |
.............................................................Investment income due and accrued |
.......................123,533 |
................................... |
.......................123,533 |
...................... 111,475 |
||||
|
15. |
Premiums and considerations: |
||||||||
|
15.1 Uncollected premiums and agents' balances in the course of collection |
4,330,259 |
................................... |
4,330,259 |
4,725,465 |
|||||
|
15.2 Deferred premiums, agents' balances and installments booked but |
|||||||||
|
...................................deferred and not yet due (including $ |
|||||||||
|
............................................................earned but unbilled premiums) |
............... 122,221,200 |
................................... |
............... 122,221,200 |
............... 108,251,925 |
|||||
|
...................................15.3 Accrued retrospective premiums ($ |
) and |
||||||||
|
contracts subject to redetermination ($ |
) |
................................... |
................................... |
................................... |
................................... |
||||
|
16. |
Reinsurance: |
||||||||
|
....................................................16.1 Amounts recoverable from reinsurers |
................................... |
................................... |
................................... |
................................... |
|||||
|
..........................16.2 Funds held by or deposited with reinsured companies |
................................... |
................................... |
................................... |
................................... |
|||||
|
........................16.3 Other amounts receivable under reinsurance contracts |
................................... |
................................... |
................................... |
................................... |
|||||
|
17. |
Amounts receivable relating to uninsured plans |
................................... |
................................... |
................................... |
................................... |
||||
|
18.1 |
Current federal and foreign income tax recoverable and interest thereon .... |
9,104 |
................................... |
9,104 |
4,193 |
||||
|
18.2 |
...................................................................................Net deferred tax asset |
................................... |
................................... |
................................... |
................................... |
||||
|
19. |
......................................................Guaranty funds receivable or on deposit |
................................... |
................................... |
................................... |
................................... |
||||
|
20. |
.....................................Electronic data processing equipment and software |
................................... |
................................... |
................................... |
................................... |
||||
|
21. |
Furniture and equipment, including health care delivery assets |
||||||||
|
($ |
) |
................................... |
................................... |
................................... |
................................... |
||||
|
22. |
.........Net adjustment in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
................................... |
................................... |
||||
|
23. |
.....................................Receivables from parent, subsidiaries and affiliates |
................................... |
................................... |
................................... |
................................... |
||||
|
24. |
Health care ($ |
) and other amounts receivable |
................................... |
................................... |
................................... |
................................... |
|||
|
25. |
Aggregate write-ins for other than invested assets |
................................... |
................................... |
................................... |
................................... |
||||
|
26. |
Total assets excluding Separate Accounts, Segregated Accounts and |
||||||||
|
Protected Cell Accounts (Lines 12 to 25) |
140,680,384 |
................................... |
140,680,384 |
126,786,780 |
|||||
|
27. |
From Separate Accounts, Segregated Accounts and Protected Cell |
||||||||
|
Accounts |
................................... |
................................... |
................................... |
................................... |
|||||
|
28. |
Total (Lines 26 and 27) |
140,680,384 |
140,680,384 |
126,786,780 |
|||||
|
DETAILS OF WRITE-INS |
|||||||||
1101. ........................................................................................................................ .................................... .................................... .................................... ....................................
1102. ........................................................................................................................ .................................... .................................... .................................... ....................................
1103. ........................................................................................................................ .................................... .................................... .................................... ....................................
1198. Summary of remaining write-ins for Line 11 from overflow page ................... ................................... ................................... ................................... ...................................
1199. Totals (Lines 1101 thru 1103 plus 1198)(Line 11 above)
2501. ........................................................................................................................ .................................... .................................... .................................... ....................................
2502. ........................................................................................................................ .................................... .................................... .................................... ....................................
2503. ........................................................................................................................ .................................... .................................... .................................... ....................................
2598. Summary of remaining write-ins for Line 25 from overflow page ................... ................................... ................................... ................................... ...................................
2599. Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above)
2
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
LIABILITIES, SURPLUS AND OTHER FUNDS
|
1 |
2 |
||||
|
Current Year |
Prior Year |
||||
|
1. |
Losses (Part 2A, Line 35, Column 8) |
........................................................................................................................................ |
................................... |
................................... |
|
|
2. |
.....................................Reinsurance payable on paid losses and loss adjustment expenses (Schedule F, Part 1, Column 6) |
................................... |
................................... |
||
|
3. |
.........................................................................................................Loss adjustment expenses (Part 2A, Line 35, Column 9) |
................................... |
................................... |
||
|
4. |
.............................................................................Commissions payable, contingent commissions and other similar charges |
................................... |
................................... |
||
|
5. |
...............................................................................................................Other expenses (excluding taxes, licenses and fees) |
................................... |
................................... |
||
|
6. |
...................................................................................Taxes, licenses and fees (excluding federal and foreign income taxes) |
................................... |
................................... |
||
|
7.1 |
...................................Current federal and foreign income taxes (including $ |
on realized capital gains (losses)) |
................................... |
................................... |
|
|
7.2 |
Net deferred tax liability |
..........................7,812 |
..........................2,699 |
||
|
8. |
Borrowed money $ |
and interest thereon $ |
.......................................... |
................................... |
................................... |
9. Unearned premiums (Part 1A, Line 38, Column 5) (after deducting unearned premiums for ceded reinsurance of
|
$ |
190,750,880 |
and including warranty reserves of $ |
and accrued accident and |
||||
|
health experience rating refunds including $ |
for |
medical loss ratio rebate per the Public Health |
|||||
|
.............................................................................................................................................................................Service Act) |
................................... |
................................... |
|||||
|
10. |
.....................................................................................................................................................................Advance premium |
................................... |
................................... |
||||
|
11. |
Dividends declared and unpaid: |
||||||
|
......................................................................................................................................................................11.1 Stockholders |
................................... |
................................... |
|||||
|
.....................................................................................................................................................................11.2 Policyholders |
................................... |
................................... |
|||||
|
12. |
........................................................................................Ceded reinsurance premiums payable (net of ceding commissions) |
................126,537,824 |
................112,949,374 |
||||
|
13. |
Funds held by company under reinsurance treaties (Schedule F, Part 3, Column 20) |
............................................................. |
................................... |
................................... |
|||
|
14. |
Amounts withheld or retained by company for account of others |
.............................................................................................. |
................................... |
................................... |
|||
|
15. |
Remittances and items not allocated |
..........................9,825 |
........................ 17,516 |
||||
|
16. |
...................................Provision for reinsurance (including $ |
.........................certified) (Schedule F, Part 3, Column 78) |
................................... |
................................... |
|||
|
17. |
...................................................................................Net adjustments in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
||||
|
18. |
.....................................................................................................................................................................Drafts outstanding |
................................... |
................................... |
||||
|
19. |
............................................................................................................................Payable to parent, subsidiaries and affiliates |
............................. 645 |
............................. 521 |
||||
|
20. |
Derivatives |
................................... |
................................... |
||||
|
21. |
................................................................................................................................................................Payable for securities |
................................... |
................................... |
||||
|
22. |
....................................................................................................................................................Payable for securities lending |
................................... |
................................... |
||||
|
23. |
......................................................................................................................Liability for amounts held under uninsured plans |
................................... |
................................... |
||||
|
24. |
Capital notes $ |
...................................and interest thereon $ |
................................................. |
................................... |
................................... |
||
|
25. |
Aggregate write-ins for liabilities |
||||||
|
26. |
Total liabilities excluding protected cell liabilities (Lines 1 through 25) |
............... 126,556,106 |
................112,970,110 |
||||
|
27. |
Protected cell liabilities |
||||||
|
28. |
Total liabilities (Lines 26 and 27) |
............... 126,556,106 |
................112,970,110 |
||||
|
29. |
............................................................................................................................Aggregate write-ins for special surplus funds |
................................... |
................................... |
||||
|
30. |
...............................................................................................................................................................Common capital stock |
...................2,350,000 |
...................2,350,000 |
||||
|
31. |
...............................................................................................................................................................Preferred capital stock |
................................... |
................................... |
||||
|
32. |
...........................................................................................................Aggregate write-ins for other than special surplus funds |
................................... |
................................... |
||||
|
33. |
.............................................................................................................................................................................Surplus notes |
................................... |
................................... |
||||
|
34. |
.......................................................................................................................................Gross paid in and contributed surplus |
...................2,675,000 |
...................2,675,000 |
||||
|
35. |
.......................................................................................................................................................Unassigned funds (surplus) |
...................9,099,278 |
................... 8,791,670 |
||||
|
36. |
Less treasury stock, at cost: |
||||||
|
36.1 |
shares common (value included in Line 30 |
$ |
) |
................................... |
................................... |
||
|
36.2 |
shares preferred (value included in Line 31 |
$ |
) |
................................... |
................................... |
||
|
37. |
Surplus as regards policyholders (Lines 29 to 35, less 36) (Page 4, Line 39) |
14,124,278 |
13,816,670 |
||||
|
38. |
TOTALS (Page 2, Line 28, Col. 3) |
140,680,384 |
126,786,780 |
||||
|
DETAILS OF WRITE-INS |
|||||||
|
2501 |
.................................... |
||||||
|
2502 |
.................................... |
||||||
|
2503 |
.................................... |
||||||
|
2598. |
Summary of remaining write-ins for Line 25 from overflow page |
.............................................................................................. |
................................... |
................................... |
|||
|
2599. |
Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) |
||||||
|
2901 |
.................................... |
||||||
|
2902 |
.................................... |
||||||
|
2903 |
.................................... |
||||||
|
2998. |
Summary of remaining write-ins for Line 29 from overflow page |
.............................................................................................. |
................................... |
................................... |
|||
|
2999. |
Totals (Lines 2901 thru 2903 plus 2998)(Line 29 above) |
||||||
|
3201. |
...................................................................................................................................................................................................................................... |
.................................... |
3202. ........................................................................................................................................................................................................................................ ....................................
3203. ........................................................................................................................................................................................................................................ ....................................
3298. Summary of remaining write-ins for Line 32 from overflow page .............................................................................................. ................................... ...................................
3299. Totals (Lines 3201 thru 3203 plus 3298)(Line 32 above)
3
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
STATEMENT OF INCOME
|
1 |
2 |
|||
|
Current Year |
Prior Year |
|||
|
UNDERWRITING INCOME |
||||
|
1. |
Premiums earned (Part 1, Line 35, Column 4) |
................................... |
................................... |
|
|
DEDUCTIONS: |
||||
|
2. |
Losses incurred (Part 2, Line 35, Column 7) |
................................... |
................................... |
|
|
3. |
Loss adjustment expenses incurred (Part 3, Line 25, Column 1) |
................................... |
................................... |
|
|
4. |
Other underwriting expenses incurred (Part 3, Line 25, Column 2) |
................................... |
................................... |
|
|
5. |
Aggregate write-ins for underwriting deductions |
................................... |
................................... |
|
|
6. |
Total underwriting deductions (Lines 2 through 5) |
|||
|
7. |
Net income of protected cells |
................................... |
................................... |
|
|
8. |
Net underwriting gain (loss) (Line 1 minus Line 6 plus Line 7) |
................................... |
................................... |
|
|
INVESTMENT INCOME |
||||
|
9. |
............................................................................Net investment income earned (Exhibit of Net Investment Income, Line 17) |
.......................392,711 |
.......................303,650 |
|
|
10. |
Net realized capital gains (losses) less capital gains tax of $ |
(Exhibit of Capital |
||
|
Gains (Losses) ) |
(30,775) |
(105,775) |
||
|
11. |
Net investment gain (loss) (Lines 9 + 10) |
361,936 |
197,875 |
|
|
OTHER INCOME |
12. Net gain (loss) from agents' or premium balances charged off (amount recovered
|
$ |
amount charged off $ |
) |
................................... |
|
|
13. |
Finance and service charges not included in premiums |
................................... |
................................... |
|
|
14. |
Aggregate write-ins for miscellaneous income |
|||
|
15. |
..................................................................................................................................Total other income (Lines 12 through 14) |
|||
|
16. |
Net income before dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes |
|||
|
(Lines 8 + 11 + 15) |
361,936 |
.......................197,875 |
- Dividends to policyholders .........................................................................................................................................................
- Net income, after dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes
|
(Line 16 minus Line 17) |
361,936 |
197,875 |
||
|
19. |
Federal and foreign income taxes incurred |
49,215 |
21,164 |
|
|
20. |
Net income (Line 18 minus Line 19)(to Line 22) |
176,711 |
||
|
CAPITAL AND SURPLUS ACCOUNT |
||||
|
21. |
Surplus as regards policyholders, |
13,816,670 |
................. 13,641,421 |
|
|
22. |
Net income (from Line 20) |
312,721 |
176,711 |
|
|
23. |
Net transfers (to) from Protected Cell accounts |
................................... |
................................... |
|
|
24. |
Change in net unrealized capital gains or (losses) less capital gains tax of $ |
.............................. |
................................... |
................................... |
|
25. |
Change in net unrealized foreign exchange capital gain (loss) |
................................... |
................................... |
|
|
26. |
Change in net deferred income tax |
........................ (5,113) |
........................ (1,462) |
|
|
27. |
Change in nonadmitted assets (Exhibit of Nonadmitted Assets, Line 28, Col. 3) |
................................... |
................................... |
|
|
28. |
Change in provision for reinsurance (Page 3, Line 16, Column 2 minus Column 1) |
................................... |
................................... |
|
|
29. |
Change in surplus notes |
................................... |
................................... |
|
|
30. |
Surplus (contributed to) withdrawn from protected cells |
................................... |
................................... |
|
|
31. |
Cumulative effect of changes in accounting principles |
................................... |
................................... |
|
|
32. |
Capital changes: |
|||
|
32.1 Paid in |
................................... |
................................... |
||
|
32.2 Transferred from surplus (Stock Dividend) |
................................... |
................................... |
||
|
32.3 Transferred to surplus |
................................... |
................................... |
||
|
33. |
Surplus adjustments: |
|||
|
33.1 Paid in |
................................... |
................................... |
||
|
33.2 Transferred to capital (Stock Dividend) |
................................... |
................................... |
||
|
33.3 Transferred from capital |
................................... |
................................... |
||
|
34. |
Net remittances from or (to) Home Office |
................................... |
................................... |
|
|
35. |
Dividends to stockholders |
................................... |
................................... |
|
|
36. |
Change in treasury stock (Page 3, Lines 36.1 and 36.2, Column 2 minus Column 1) |
................................... |
................................... |
|
|
37. |
Aggregate write-ins for gains and losses in surplus |
|||
|
38. |
Change in surplus as regards policyholders for the year (Lines 22 through 37) |
307,608 |
175,249 |
|
|
39. |
Surplus as regards policyholders, |
14,124,278 |
13,816,670 |
|
|
DETAILS OF WRITE-INS |
0501. ........................................................................................................................................................................................................................................ ....................................
0502. ........................................................................................................................................................................................................................................ ....................................
0503. ........................................................................................................................................................................................................................................ ....................................
0598. Summary of remaining write-ins for Line 5 from overflow page ................................................................................................ ................................... ...................................
0599. Totals (Lines 0501 thru 0503 plus 0598)(Line 5 above)
1401. ........................................................................................................................................................................................................................................ ....................................
1402. ........................................................................................................................................................................................................................................ ....................................
1403. ........................................................................................................................................................................................................................................ ....................................
1498. Summary of remaining write-ins for Line 14 from overflow page .............................................................................................. ................................... ...................................
1499. Totals (Lines 1401 thru 1403 plus 1498)(Line 14 above)
3701. ........................................................................................................................................................................................................................................ ....................................
3702. ........................................................................................................................................................................................................................................ ....................................
3703. ........................................................................................................................................................................................................................................ ....................................
3798. Summary of remaining write-ins for Line 37 from overflow page .............................................................................................. ................................... ...................................
3799. Totals (Lines 3701 thru 3703 plus 3798)(Line 37 above)
4
ANNUAL STATEMENT FOR THE YEAR 2023 OF THE
CASH FLOW
Cash from Operations
1
Current Year
2
Prior Year
|
1. |
Premiums collected net of reinsurance |
........................ 14,382 |
..........................1,844 |
|
|
2. |
Net investment income |
.......................470,976 |
.......................437,813 |
|
|
3. |
Miscellaneous income |
|||
|
4. |
Total (Lines 1 through 3) |
485,358 |
439,657 |
|
|
5. |
Benefit and loss related payments |
................................... |
................................... |
|
|
6. |
.......................................................Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts |
................................... |
................................... |
|
|
7. |
Commissions, expenses paid and aggregate write-ins for deductions |
................................... |
................................... |
|
|
8. |
Dividends paid to policyholders |
................................... |
................................... |
|
|
9. |
Federal and foreign income taxes paid (recovered) net of $ |
tax on capital gains (losses) |
54,126 |
22,018 |
|
10. |
Total (Lines 5 through 9) |
54,126 |
22,018 |
|
|
11. |
Net cash from operations (Line 4 minus Line 10) |
431,232 |
417,639 |
|
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
|
12.1 |
Bonds |
1,437,395 |
2,837,619 |
|
12.2 |
Stocks |
................................... |
................................... |
|
12.3 |
Mortgage loans |
................................... |
................................... |
|
12.4 |
Real estate |
................................... |
................................... |
|
12.5 |
Other invested assets |
................................... |
................................... |
|
12.6 |
Net gains or (losses) on cash, cash equivalents and short-term investments |
................................... |
................................... |
|
12.7 |
Miscellaneous proceeds |
||
|
12.8 Total investment proceeds (Lines 12.1 to 12.7) |
................... 1,437,395 |
................... 2,837,619 |
13. Cost of investments acquired (long-term only):
|
13.1 |
Bonds |
2,124,215 |
2,709,262 |
|
|
13.2 |
Stocks |
................................... |
................................... |
|
|
13.3 |
Mortgage loans |
................................... |
................................... |
|
|
13.4 |
Real estate |
................................... |
................................... |
|
|
13.5 |
Other invested assets |
................................... |
................................... |
|
|
13.6 |
Miscellaneous applications |
377,930 |
98 |
|
|
13.7 |
Total investments acquired (Lines 13.1 to 13.6) |
2,502,145 |
2,709,360 |
|
|
14. |
.................................................................................................Net increase/(decrease) in contract loans and premium notes |
|||
|
15. |
Net cash from investments (Line 12.8 minus Line 13.7 minus Line 14) |
(1,064,750) |
128,260 |
|
|
Cash from Financing and Miscellaneous Sources |
||||
|
16. |
Cash provided (applied): |
|||
|
16.1 |
Surplus notes, capital notes |
................................... |
................................... |
|
|
16.2 Capital and paid in surplus, less treasury stock |
................................... |
................................... |
||
|
.................................................................................................................................................................16.3 Borrowed funds |
................................... |
................................... |
||
|
..............................................................................16.4 Net deposits on deposit-type contracts and other insurance liabilities |
................................... |
................................... |
||
|
.................................................................................................................................................16.5 Dividends to stockholders |
................................... |
................................... |
||
|
...........................................................................................................................................16.6 Other cash provided (applied) |
(7,568) |
(5,780) |
||
|
17. |
Net cash from financing and miscellaneous sources (Lines 16.1 to 16.4 minus Line 16.5 plus Line 16.6) |
(7,568) |
(5,780) |
|
|
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS |
||||
|
18. |
........................................Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17) |
(641,086) |
540,119 |
|
|
19. |
Cash, cash equivalents and short-term investments: |
|||
|
...............................................................................................................................................................19.1 Beginning of year |
...................1,302,849 |
.......................762,730 |
||
|
19.2 End of period (Line 18 plus Line 19.1) |
661,763 |
1,302,849 |
Note: Supplemental disclosures of cash flow information for non-cash transactions:
5
Attachments
Disclaimer



FTI Consulting Acquires Madison Consulting Group
December 2023 Erie Family Life Insurance Company
Advisor News
- Study finds more households move investable assets across firms
- Could workplace benefits help solve America’s long-term care gap?
- The best way to use a tax refund? Create a holistic plan
- CFP Board appoints K. Dane Snowden as CEO
- TIAA unveils ‘policy roadmap’ to boost retirement readiness
More Advisor NewsAnnuity News
- $80k surrender charge at stake as Navy vet, Ameritas do battle in court
- Sammons Institutional Group® Launches Summit LadderedSM
- Protective Expands Life & Annuity Distribution with Alfa Insurance
- Annuities: A key tool in battling inflation
- Pinnacle Financial Services Launches New Agent Website, Elevating the Digital Experience for Independent Agents Nationwide
More Annuity NewsHealth/Employee Benefits News
- Providers fear illness uptick
- JAN. 30, 2026: NATIONAL ADVOCACY UPDATE
- Advocates for elderly target utility, insurance costs
- National Health Insurance Service Ilsan Hospital Describes Findings in Gastric Cancer (Incidence and risk factors for symptomatic gallstone disease after gastrectomy for gastric cancer: a nationwide population-based study): Oncology – Gastric Cancer
- Reports from Stanford University School of Medicine Highlight Recent Findings in Mental Health Diseases and Conditions (PERSPECTIVE: Self-Funded Group Health Plans: A Public Mental Health Threat to Employees?): Mental Health Diseases and Conditions
More Health/Employee Benefits NewsLife Insurance News